Offer - Urjas Oil for just ₹ 1 X
Rheoran SF 50 Mcg/250 Mcg Octacap is a commercial drug that is prescribed in the form of Capsule. Secondary and off-label uses of Rheoran SF 50 Mcg/250 Mcg Octacap have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Rheoran SF 50 Mcg/250 Mcg Octacap. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Rheoran SF 50 Mcg/250 Mcg Octacap also has some side effects, the most common being Shortness of Breath, Throat Irritation, Nosebleed. Apart from the aforementioned side effects, Rheoran SF 50 Mcg/250 Mcg Octacap can also lead to other problems, which have been listed below. Normally, these side effects of Rheoran SF 50 Mcg/250 Mcg Octacap are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Rheoran SF 50 Mcg/250 Mcg Octacap has a Moderate effect for pregnant women and Mild effect on lactating mothers. Warnings related to Rheoran SF 50 Mcg/250 Mcg Octacap's effects on the liver, heart and kidney, if any, have been listed below.
Other conditions have been mentioned below in the Rheoran SF 50 Mcg/250 Mcg Octacap contraindications section.
Besides this, Rheoran SF 50 Mcg/250 Mcg Octacap may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Rheoran SF 50 Mcg/250 Mcg Octacap is safe while driving, and is is addictive in nature.
Rheoran SF 50 Mcg/250 Mcg Octacap is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Rheoran SF 50 Mcg/250 Mcg Octacap safe for pregnant women?
Pregnant women may experience moderate side effects from Rheoran SF. It is best to stop taking Rheoran SF immediately and inform your doctor if you notice any discomfort.
Is the use of Rheoran SF 50 Mcg/250 Mcg Octacap safe during breastfeeding?
Rheoran SF may have very limited harmful effects for breastfeeding women.
What is the effect of Rheoran SF 50 Mcg/250 Mcg Octacap on the Kidneys?
Rheoran SF is completely safe for kidneys.
What is the effect of Rheoran SF 50 Mcg/250 Mcg Octacap on the Liver?
The liver can be affected by Rheoran SF. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Rheoran SF only after medical advice.
What is the effect of Rheoran SF 50 Mcg/250 Mcg Octacap on the Heart?
You may experience side effects on your heart after taking Rheoran SF. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Rheoran SF 50 Mcg/250 Mcg Octacap unless your doctor advises you to do so -
Is this Rheoran SF 50 Mcg/250 Mcg Octacap habit forming or addictive?
Rheoran SF 50 Mcg/250 Mcg Octacap does not cause addiction.
Interaction between Food and Rheoran SF 50 Mcg/250 Mcg Octacap
Due to a lack of research, nothing can be said about the consequences of taking Rheoran SF 50 Mcg/250 Mcg Octacap together with food.
Interaction between Alcohol and Rheoran SF 50 Mcg/250 Mcg Octacap
No research has been done on this till date. Therefore, it is not known what the effect of taking Rheoran SF 50 Mcg/250 Mcg Octacap with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359